Apogee Therapeutics, Inc.
APGE
Rankning i aktier
#2362
Apogee Therapeutics, Inc. is a biotechnology firm, operating via its... Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders. Its primary focus includes APG777, a subcutaneous (SQ) monoclonal antibody (mAb) engineered for an extended half-life to treat AD, and APG808, a similarly formulated SQ extended half-life mAb targeting COPD. Furthermore, its earlier-stage pipeline features APG990, another SQ extended half-life mAb designed for AD, and APG222, comprising extended half-life subcutaneous antibodies also aimed at AD. Established in 2022, the company maintains its headquarters in Waltham, Massachusetts.
Aktiekurs
$135.07
Senast synkroniserad: 2026-09-04
Marknadsvärde
$8.36B
Förändring (1 dag)
0.00%
Förändring (1 år)
141.76%
Land
US
Handel Apogee Therapeutics, Inc. (APGE)
Kategori
Healthcare
Historik för aktiesplit för Apogee Therapeutics, Inc. (APGE)
Aktien Apogee Therapeutics, Inc. (symbol: APGE) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 21, 2026.
En APGE-aktie köpt före Oct 21, 2026 motsvarar nu 0 APGE-aktier.
Den senaste spliten skedde den Oct 21, 2026.
En APGE-aktie köpt före Oct 21, 2026 motsvarar nu 0 APGE-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | |||
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
